Although we mention only a few of the most prominent clinical trials, liraglutide and tirzepatide show consistent efficacy of GLP-1 and GIP/GLP-1 receptor agonists in obstructive sleep apnea settings. The gene discussed is GLP1R; the disease is obstructive sleep apnea syndrome.